University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Acamprosate E/C tablets
Status: Amber Acenocoumarol tablets
Status: Amber Acetazolamide

Intercranial hypertension (unlicensed indication)

Status: Amber Acetazolamide M/R capsules

Specialist ophthalmologist recommendation - acetazolamide M/R capsules and tablets

Status: Amber Acetazolamide tablets

Specialist ophthalmologist recommendation - acetazolamide M/R cpasules and tablets

Status: Amber Acetylclonidine 0.5% eye drops
Status: Amber Aciclovir 3% eye ointment
Status: Amber Agomelatine

Specialist initiation only, RICaD

Status: Amber Alfacalcidol (One-Alpha)
Status: Amber Alimemazine (Trimeprazine)

For children as per guideline

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top